A comparison of primary and passaged chondrocytes for use in engineering the temporomandibular joint.

Department of Bioengineering: MS-142, Rice University, P.O. Box 1892, Houston, TX 77251, USA.
Archives of oral biology (Impact Factor: 1.88). 12/2008; 54(2):138-45. DOI: 10.1016/j.archoralbio.2008.09.018
Source: PubMed

ABSTRACT This study examines the tissue engineering potential of passaged (P3) and primary (P0) articular chondrocytes (ACs) and costal chondrocytes (CCs) from skeletally mature goats for use in the temporomandibular joint (TMJ).
These four cell types were assembled into scaffoldless tissue engineered constructs and cultured for 4 wks. The constructs were then tested for cell, collagen, and glycosaminoglycan (GAG) content with biochemical assays, and collagen types I and II with enzyme-linked immunosorbent assays. Constructs were also tested under tension and compression to determine biomechanical properties.
Both primary and passaged CC constructs had greater GAG/wet weight than AC constructs. Primary AC constructs had significantly less total collagen and contained no collagen type I. AC P3 constructs had the largest collagen I/collagen II ratio, which was also greater in passaged CC constructs relative to primary groups. Primary AC constructs were not mechanically testable, whereas passaged AC and CC constructs had significantly greater tensile properties than primary CC constructs.
Primary CCs are considerably better than primary ACs and have potential use in tissue engineering when larger quantities of collagen type II are desired. The poor performance of the ACs, in this study, which contradicts the results seen with previous studies using immature bovine ACs, may thus be attributed to the animals' maturity. However, CC P3 cells appear particularly well suited for tissue engineering fibrocartilage of the TMJ due to the high quantity of collagen and GAG, and tensile and compressive mechanical properties.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: TMJ disc related diseases are difficult to be cured due to the poor repair ability of the disc. TMJ-SDSCs were ideal cell sources for cartilage tissue engineering which have been widely used in hyaline cartilage regeneration. Fibrin gel has been demonstrated as a potential scaffold for neocartilage formation. The aim of this study was to repair the TMJ disc perforation using fibrin/chitosan hybrid scaffold combined with TMJ-SDSCs. Rat TMJ-SDSCs were cultured on hybrid scaffold or pure chitosan scaffolds. The cell seeding efficiency, distribution, proliferation, and chondrogenic differentiation capacity were investigated. To evaluate the in vivo repair ability of cell/scaffold construct, rat TMJ disc explants were punched with a defect to mimic TMJ disc perforation. Cell seeded scaffolds were inserted into the defect of TMJ disc explants and then were implanted subcutaneously in nude mice for 4 weeks. Results demonstrated that fibrin may improve cell seeding, proliferation, and chondrogenic induction in vitro. The in vivo experiments showed more cartilage ECM deposition in fibrin/chitosan scaffold, which suggested an enhanced reparative ability. This pilot study demonstrated that the regenerative ability of TMJ-SDSCs seeded in fibrin/chitosan scaffold could be applied for repairing TMJ disc perforation.
    04/2014; 2014:454021. DOI:10.1155/2014/454021
  • [Show abstract] [Hide abstract]
    ABSTRACT: The combination of reduced oxygen tension and flow perfusion bioreactor culture is investigated for its effect on the proliferation, glycosaminoglycan production, and chondrogenic gene expression of bovine articular chondrocytes on porous polymer scaffolds. It was hypothesized that the combination of such factors would more closely replicate the in situ environment of these cells, leading to improvements in the cell phenotype. Chondrocytes were seeded onto electrospun poly(ε‐caprolactone) scaffolds and cultured in static or perfusion culture in either normoxic or hypoxic conditions for 6days. Results demonstrated that the combination of hypoxic and perfusion culture led to an increase in chondrocyte proliferation and glycosaminoglycan production, as well as an improvement in the ratio of collagen II/I gene expression over perfusion culture alone. The results demonstrate the need to combine multiple signals in vitro, in order to improve tissue growth by more closely replicating the native environment of cells. © 2013 American Institute of Chemical Engineers AIChE J, 59: 3158–3166, 2013
    AIChE Journal 09/2013; 59(9). DOI:10.1002/aic.13958 · 2.58 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The objective of this review is to inform practitioners with the most updated information on tissue engineering and its potential applications in dentistry. Data The authors used “PUBMED” to find relevant literature written in English and published from the beginning of tissue engineering until today. A combination of key words was used as the search terms e.g., “tissue engineering”, “approaches”, “strategies” “dentistry”, “dental stem cells”, “dentino-pulp complex”, “guided tissue regeneration”, “whole tooth”, “TMJ”, “condyle”, “salivary glands”, and “oral mucosa”. Sources Abstracts and full text articles were used to identify causes of craniofacial tissue loss, different approaches for craniofacial reconstructions, how the tissue engineering emerges, different strategies of tissue engineering, biomaterials employed for this purpose, the major attempts to engineer different dental structures, finally challenges and future of tissue engineering in dentistry. Study selection Only those articles that dealt with the tissue engineering in dentistry were selected. Conclusions There has been a recent surge in guided tissue engineering methods to manage periodontal diseases beyond the traditional approaches. However, the predictable reconstruction of the innate organisation and function of whole teeth as well as their periodontal structures remains challenging. Despite some limited progress and minor successes, there remain distinct and important challenges in the development of reproducible and clinically safe approaches for oral tissue repair and regeneration. Clearly, there is a convincing body of evidence which confirms the need for this type of treatment, and public health data worldwide indicates a more than adequate patient resource. The future of these therapies involving more biological approaches and the use of dental tissue stem cells is promising and advancing. Also there may be a significant interest of their application and wider potential to treat disorders beyond the craniofacial region.
    Journal of Dentistry 08/2014; DOI:10.1016/j.jdent.2014.05.008 · 2.84 Impact Factor

Full-text (2 Sources)

Available from
May 21, 2014